Copyright Reports & Markets. All rights reserved.

Global Drug of Abuse (DOA) Testing Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Urine
    • 1.2.3 Saliva
    • 1.2.4 Hair
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Drug of Abuse (DOA) Testing Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospitals
    • 1.3.3 Laboratories
    • 1.3.4 Workplace
    • 1.3.5 At-Home
    • 1.3.6 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Drug of Abuse (DOA) Testing Market Perspective (2016-2027)
  • 2.2 Drug of Abuse (DOA) Testing Growth Trends by Regions
    • 2.2.1 Drug of Abuse (DOA) Testing Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Drug of Abuse (DOA) Testing Historic Market Share by Regions (2016-2021)
    • 2.2.3 Drug of Abuse (DOA) Testing Forecasted Market Size by Regions (2022-2027)
  • 2.3 Drug of Abuse (DOA) Testing Industry Dynamic
    • 2.3.1 Drug of Abuse (DOA) Testing Market Trends
    • 2.3.2 Drug of Abuse (DOA) Testing Market Drivers
    • 2.3.3 Drug of Abuse (DOA) Testing Market Challenges
    • 2.3.4 Drug of Abuse (DOA) Testing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Drug of Abuse (DOA) Testing Players by Revenue
    • 3.1.1 Global Top Drug of Abuse (DOA) Testing Players by Revenue (2016-2021)
    • 3.1.2 Global Drug of Abuse (DOA) Testing Revenue Market Share by Players (2016-2021)
  • 3.2 Global Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Drug of Abuse (DOA) Testing Revenue
  • 3.4 Global Drug of Abuse (DOA) Testing Market Concentration Ratio
    • 3.4.1 Global Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Drug of Abuse (DOA) Testing Revenue in 2020
  • 3.5 Drug of Abuse (DOA) Testing Key Players Head office and Area Served
  • 3.6 Key Players Drug of Abuse (DOA) Testing Product Solution and Service
  • 3.7 Date of Enter into Drug of Abuse (DOA) Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Drug of Abuse (DOA) Testing Breakdown Data by Type

  • 4.1 Global Drug of Abuse (DOA) Testing Historic Market Size by Type (2016-2021)
  • 4.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2022-2027)

5 Drug of Abuse (DOA) Testing Breakdown Data by Application

  • 5.1 Global Drug of Abuse (DOA) Testing Historic Market Size by Application (2016-2021)
  • 5.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Drug of Abuse (DOA) Testing Market Size (2016-2027)
  • 6.2 North America Drug of Abuse (DOA) Testing Market Size by Type
    • 6.2.1 North America Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
    • 6.2.2 North America Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
    • 6.2.3 North America Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
  • 6.3 North America Drug of Abuse (DOA) Testing Market Size by Application
    • 6.3.1 North America Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
    • 6.3.2 North America Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
    • 6.3.3 North America Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
  • 6.4 North America Drug of Abuse (DOA) Testing Market Size by Country
    • 6.4.1 North America Drug of Abuse (DOA) Testing Market Size by Country (2016-2021)
    • 6.4.2 North America Drug of Abuse (DOA) Testing Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Drug of Abuse (DOA) Testing Market Size (2016-2027)
  • 7.2 Europe Drug of Abuse (DOA) Testing Market Size by Type
    • 7.2.1 Europe Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
    • 7.2.2 Europe Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
    • 7.2.3 Europe Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
  • 7.3 Europe Drug of Abuse (DOA) Testing Market Size by Application
    • 7.3.1 Europe Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
    • 7.3.2 Europe Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
    • 7.3.3 Europe Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
  • 7.4 Europe Drug of Abuse (DOA) Testing Market Size by Country
    • 7.4.1 Europe Drug of Abuse (DOA) Testing Market Size by Country (2016-2021)
    • 7.4.2 Europe Drug of Abuse (DOA) Testing Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Drug of Abuse (DOA) Testing Market Size (2016-2027)
  • 8.2 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Type
    • 8.2.1 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Application
    • 8.3.1 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region
    • 8.4.1 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Drug of Abuse (DOA) Testing Market Size (2016-2027)
  • 9.2 Latin America Drug of Abuse (DOA) Testing Market Size by Type
    • 9.2.1 Latin America Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
    • 9.2.2 Latin America Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
    • 9.2.3 Latin America Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
  • 9.3 Latin America Drug of Abuse (DOA) Testing Market Size by Application
    • 9.3.1 Latin America Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
    • 9.3.2 Latin America Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
    • 9.3.3 Latin America Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
  • 9.4 Latin America Drug of Abuse (DOA) Testing Market Size by Country
    • 9.4.1 Latin America Drug of Abuse (DOA) Testing Market Size by Country (2016-2021)
    • 9.4.2 Latin America Drug of Abuse (DOA) Testing Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Drug of Abuse (DOA) Testing Market Size (2016-2027)
  • 10.2 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Type
    • 10.2.1 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Application
    • 10.3.1 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country
    • 10.4.1 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Siemens
    • 11.1.1 Siemens Company Details
    • 11.1.2 Siemens Business Overview
    • 11.1.3 Siemens Drug of Abuse (DOA) Testing Introduction
    • 11.1.4 Siemens Revenue in Drug of Abuse (DOA) Testing Business (2016-2021)
    • 11.1.5 Siemens Recent Development
  • 11.2 Merck
    • 11.2.1 Merck Company Details
    • 11.2.2 Merck Business Overview
    • 11.2.3 Merck Drug of Abuse (DOA) Testing Introduction
    • 11.2.4 Merck Revenue in Drug of Abuse (DOA) Testing Business (2016-2021)
    • 11.2.5 Merck Recent Development
  • 11.3 Roche
    • 11.3.1 Roche Company Details
    • 11.3.2 Roche Business Overview
    • 11.3.3 Roche Drug of Abuse (DOA) Testing Introduction
    • 11.3.4 Roche Revenue in Drug of Abuse (DOA) Testing Business (2016-2021)
    • 11.3.5 Roche Recent Development
  • 11.4 Thermo Fisher Scientific
    • 11.4.1 Thermo Fisher Scientific Company Details
    • 11.4.2 Thermo Fisher Scientific Business Overview
    • 11.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Introduction
    • 11.4.4 Thermo Fisher Scientific Revenue in Drug of Abuse (DOA) Testing Business (2016-2021)
    • 11.4.5 Thermo Fisher Scientific Recent Development
  • 11.5 Bio-Rad
    • 11.5.1 Bio-Rad Company Details
    • 11.5.2 Bio-Rad Business Overview
    • 11.5.3 Bio-Rad Drug of Abuse (DOA) Testing Introduction
    • 11.5.4 Bio-Rad Revenue in Drug of Abuse (DOA) Testing Business (2016-2021)
    • 11.5.5 Bio-Rad Recent Development
  • 11.6 Abbott
    • 11.6.1 Abbott Company Details
    • 11.6.2 Abbott Business Overview
    • 11.6.3 Abbott Drug of Abuse (DOA) Testing Introduction
    • 11.6.4 Abbott Revenue in Drug of Abuse (DOA) Testing Business (2016-2021)
    • 11.6.5 Abbott Recent Development
  • 11.7 Quest Diagnostics
    • 11.7.1 Quest Diagnostics Company Details
    • 11.7.2 Quest Diagnostics Business Overview
    • 11.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Introduction
    • 11.7.4 Quest Diagnostics Revenue in Drug of Abuse (DOA) Testing Business (2016-2021)
    • 11.7.5 Quest Diagnostics Recent Development
  • 11.8 Psychemedics
    • 11.8.1 Psychemedics Company Details
    • 11.8.2 Psychemedics Business Overview
    • 11.8.3 Psychemedics Drug of Abuse (DOA) Testing Introduction
    • 11.8.4 Psychemedics Revenue in Drug of Abuse (DOA) Testing Business (2016-2021)
    • 11.8.5 Psychemedics Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Drug of Abuse (DOA) Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drug of Abuse (DOA) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Urine
    Saliva
    Hair
    Others

    Segment by Application
    Hospitals
    Laboratories
    Workplace
    At-Home
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Siemens
    Merck
    Roche
    Thermo Fisher Scientific
    Bio-Rad
    Abbott
    Quest Diagnostics
    Psychemedics
    Thermo Fisher Scientific

    Buy now